{"id": "article-20877_0", "title": "Ecthyma Gangrenosum -- Continuing Education Activity", "content": "Ecthyma gangrenosum (EG) is a cutaneous infection that most commonly occurs in immunocompromised individuals with fulminant bacteremia. EG was first described in 1897 by Canadian pathologist Dr. Lewellys Barker as a manifestation of Pseudomonas aeruginosa. Although P. aeruginosa remains the most frequent organism identified in EG, other causative pathogens have since been described. This activity reviews the cause and presentation of ecthyma gangrenosum and highlights the interprofessional team's role in its management.", "contents": "Ecthyma Gangrenosum -- Continuing Education Activity. Ecthyma gangrenosum (EG) is a cutaneous infection that most commonly occurs in immunocompromised individuals with fulminant bacteremia. EG was first described in 1897 by Canadian pathologist Dr. Lewellys Barker as a manifestation of Pseudomonas aeruginosa. Although P. aeruginosa remains the most frequent organism identified in EG, other causative pathogens have since been described. This activity reviews the cause and presentation of ecthyma gangrenosum and highlights the interprofessional team's role in its management."}
{"id": "article-20877_1", "title": "Ecthyma Gangrenosum -- Continuing Education Activity", "content": "Objectives: Review the causes of ecthyma gangrenosum. Describe the presentation of ecthyma gangrenosum. Summarize the treatment options for ecthyma gangrenosum. Explain the importance of improving care coordination among interprofessional team members to improve outcomes for patients affected by ecthyma gangrenosum. Access free multiple choice questions on this topic.", "contents": "Ecthyma Gangrenosum -- Continuing Education Activity. Objectives: Review the causes of ecthyma gangrenosum. Describe the presentation of ecthyma gangrenosum. Summarize the treatment options for ecthyma gangrenosum. Explain the importance of improving care coordination among interprofessional team members to improve outcomes for patients affected by ecthyma gangrenosum. Access free multiple choice questions on this topic."}
{"id": "article-20877_2", "title": "Ecthyma Gangrenosum -- Introduction", "content": "Ecthyma gangrenosum (EG) is a cutaneous infection that most commonly occurs in immunocompromised individuals with fulminant bacteremia. EG was first described in 1897 by Canadian pathologist Dr. Lewellys\u00a0Barker as a manifestation of Pseudomonas aeruginosa. [1] Although P.\u00a0aeruginosa remains the most frequent organism identified\u00a0in EG, other causative pathogens have since\u00a0been described. Lesions appear as gangrenous ulcers with erythematous borders. EG\u00a0predominantly affects the axillary and anogenital areas, but the arms, legs, trunk, and face are also sometimes involved. Perivascular invasion and resultant ischemic necrosis of the associated skin result in the classic macroscopic appearance. Prompt recognition and empiric therapy with broad-spectrum antipseudomonal agents are of critical importance. Once microbiology results identify the causative pathogen and sensitivities are available, antimicrobial coverage should be narrowed. [2] EG denotes a poor prognosis, particularly in immunocompromised individuals with neutropenia.", "contents": "Ecthyma Gangrenosum -- Introduction. Ecthyma gangrenosum (EG) is a cutaneous infection that most commonly occurs in immunocompromised individuals with fulminant bacteremia. EG was first described in 1897 by Canadian pathologist Dr. Lewellys\u00a0Barker as a manifestation of Pseudomonas aeruginosa. [1] Although P.\u00a0aeruginosa remains the most frequent organism identified\u00a0in EG, other causative pathogens have since\u00a0been described. Lesions appear as gangrenous ulcers with erythematous borders. EG\u00a0predominantly affects the axillary and anogenital areas, but the arms, legs, trunk, and face are also sometimes involved. Perivascular invasion and resultant ischemic necrosis of the associated skin result in the classic macroscopic appearance. Prompt recognition and empiric therapy with broad-spectrum antipseudomonal agents are of critical importance. Once microbiology results identify the causative pathogen and sensitivities are available, antimicrobial coverage should be narrowed. [2] EG denotes a poor prognosis, particularly in immunocompromised individuals with neutropenia."}
{"id": "article-20877_3", "title": "Ecthyma Gangrenosum -- Etiology", "content": "P.\u00a0aeruginosa is the most frequent organism identified in ecthyma gangrenosum, with one study identifying P.\u00a0aeruginosa in 74% of cases. [1] P. aeruginosa is a non-lactose fermenting gram-negative aerobic, rod-shaped bacteria. The organism is found in moist environments,\u00a0is often identified in tap water samples, and can contaminate\u00a0hospital equipment leading to nosocomial infections. [3] [4] Other causes of EG include methicillin-resistant Staphylococcus aureus (MRSA), Streptococcus pyogenes , Citrobacter\u00a0freundii ,\u00a0E scherichia coli , Aeromonas hydrophila , Klebsiella pneumoniae , Serratia marcescens , Xanthomonas maltophilia , Morganella morganii , Corynebacterium diphtheriae , Neisseria gonorrhea , Yersinia pestis , fungi like the Candida species), and viruses like herpes simplex virus. [1] [5] [6] [7]", "contents": "Ecthyma Gangrenosum -- Etiology. P.\u00a0aeruginosa is the most frequent organism identified in ecthyma gangrenosum, with one study identifying P.\u00a0aeruginosa in 74% of cases. [1] P. aeruginosa is a non-lactose fermenting gram-negative aerobic, rod-shaped bacteria. The organism is found in moist environments,\u00a0is often identified in tap water samples, and can contaminate\u00a0hospital equipment leading to nosocomial infections. [3] [4] Other causes of EG include methicillin-resistant Staphylococcus aureus (MRSA), Streptococcus pyogenes , Citrobacter\u00a0freundii ,\u00a0E scherichia coli , Aeromonas hydrophila , Klebsiella pneumoniae , Serratia marcescens , Xanthomonas maltophilia , Morganella morganii , Corynebacterium diphtheriae , Neisseria gonorrhea , Yersinia pestis , fungi like the Candida species), and viruses like herpes simplex virus. [1] [5] [6] [7]"}
{"id": "article-20877_4", "title": "Ecthyma Gangrenosum -- Epidemiology", "content": "Ecthyma gangrenosum affects all age groups and genders. Immunocompromised individuals are\u00a0particularly\u00a0susceptible\u00a0to developing this condition, with up to 62% to 75% of affected individuals having an underlying immunodeficiency. [1] [8] EG\u00a0is also known to occur in otherwise healthy immunocompetent individuals. [9] Common predisposing conditions include neutropenia, leukemia, multiple myeloma, diabetes mellitus, malnutrition, and extensive burn wounds. [1] [5] [7] [10] [11]", "contents": "Ecthyma Gangrenosum -- Epidemiology. Ecthyma gangrenosum affects all age groups and genders. Immunocompromised individuals are\u00a0particularly\u00a0susceptible\u00a0to developing this condition, with up to 62% to 75% of affected individuals having an underlying immunodeficiency. [1] [8] EG\u00a0is also known to occur in otherwise healthy immunocompetent individuals. [9] Common predisposing conditions include neutropenia, leukemia, multiple myeloma, diabetes mellitus, malnutrition, and extensive burn wounds. [1] [5] [7] [10] [11]"}
{"id": "article-20877_5", "title": "Ecthyma Gangrenosum -- Pathophysiology", "content": "Ecthyma\u00a0gangrenosum\u00a0is separated into bacteremic and non-bacteremic forms. [7] The bacteremic form of EG is more common than the non-bacteremic form. [1] With bacteremia, the causative organism is spread hematogenously to the capillaries and invades the media and adventitia of arteries and veins. Perivascular invasion ultimately leads to ischemic necrosis of the surrounding skin. [12] In the non-bacteremic form, the lesions develop at the location of direct inoculation into the epidermis. Virulence toxins and enzymes produced by P. aeruginosa , such as exotoxin A, elastase, and phospholipase C,  cause skin and vascular destruction. [8] Multi-drug resistance of P. aeruginosa has increased substantially\u00a0in recent years, making treatment more challenging. Resistance mechanisms include decreased permeability (biofilm formation), antibiotic efflux pumps, antibiotic inactivating mechanisms, and antibiotic target site mutations. [12] [13]", "contents": "Ecthyma Gangrenosum -- Pathophysiology. Ecthyma\u00a0gangrenosum\u00a0is separated into bacteremic and non-bacteremic forms. [7] The bacteremic form of EG is more common than the non-bacteremic form. [1] With bacteremia, the causative organism is spread hematogenously to the capillaries and invades the media and adventitia of arteries and veins. Perivascular invasion ultimately leads to ischemic necrosis of the surrounding skin. [12] In the non-bacteremic form, the lesions develop at the location of direct inoculation into the epidermis. Virulence toxins and enzymes produced by P. aeruginosa , such as exotoxin A, elastase, and phospholipase C,  cause skin and vascular destruction. [8] Multi-drug resistance of P. aeruginosa has increased substantially\u00a0in recent years, making treatment more challenging. Resistance mechanisms include decreased permeability (biofilm formation), antibiotic efflux pumps, antibiotic inactivating mechanisms, and antibiotic target site mutations. [12] [13]"}
{"id": "article-20877_6", "title": "Ecthyma Gangrenosum -- Histopathology", "content": "Excisional biopsy or punch biopsy\u00a0with Gram stain, culture, and histopathologic examination can\u00a0be performed in equivocal cases. In cases of pseudomonal\u00a0EG, Gram stain shows\u00a0many gram-negative, rod-shaped bacteria. [14] Wound cultures are frequently positive for P. aeruginosa but may reveal a different causative organism . Microscopic examination reveals an ulcerated zone of necrotic epidermis and dermis with neutrophilic predominance. [14] [15] The epidermis adjacent to the necrotic region reveals reactive hyperkeratosis. The underlying subcutaneous tissue may also be involved. [8]", "contents": "Ecthyma Gangrenosum -- Histopathology. Excisional biopsy or punch biopsy\u00a0with Gram stain, culture, and histopathologic examination can\u00a0be performed in equivocal cases. In cases of pseudomonal\u00a0EG, Gram stain shows\u00a0many gram-negative, rod-shaped bacteria. [14] Wound cultures are frequently positive for P. aeruginosa but may reveal a different causative organism . Microscopic examination reveals an ulcerated zone of necrotic epidermis and dermis with neutrophilic predominance. [14] [15] The epidermis adjacent to the necrotic region reveals reactive hyperkeratosis. The underlying subcutaneous tissue may also be involved. [8]"}
{"id": "article-20877_7", "title": "Ecthyma Gangrenosum -- History and Physical", "content": "When acquiring a history on presentation, it is important to note the temporal evolution of the lesions, the location of the lesions, any underlying immunosuppressive condition, and other associated symptoms such as\u00a0cough, fever, or dysuria. In individuals with the bacteremic form of EG,\u00a0the source of infection is important to ascertain. For example, productive cough or dysuria may reveal a respiratory or urinary source, respectively. In the non-bacteremic form, it is important to note any trauma that may have introduced the infection via direct inoculation.", "contents": "Ecthyma Gangrenosum -- History and Physical. When acquiring a history on presentation, it is important to note the temporal evolution of the lesions, the location of the lesions, any underlying immunosuppressive condition, and other associated symptoms such as\u00a0cough, fever, or dysuria. In individuals with the bacteremic form of EG,\u00a0the source of infection is important to ascertain. For example, productive cough or dysuria may reveal a respiratory or urinary source, respectively. In the non-bacteremic form, it is important to note any trauma that may have introduced the infection via direct inoculation."}
{"id": "article-20877_8", "title": "Ecthyma Gangrenosum -- History and Physical", "content": "The lesions of ecthyma gangrenosum begin as painless, round erythematous macules and patches that develop into central pustules with surrounding erythema. A hemorrhagic vesicle appears at the center of the lesion and evolves into a gangrenous ulcer with a black eschar. [1] [8] Early lesions may progress to necrotic ulcers in as little as 12 hours. [8] The\u00a0lesions can\u00a0be localized\u00a0and solitary, or widespread. [1]", "contents": "Ecthyma Gangrenosum -- History and Physical. The lesions of ecthyma gangrenosum begin as painless, round erythematous macules and patches that develop into central pustules with surrounding erythema. A hemorrhagic vesicle appears at the center of the lesion and evolves into a gangrenous ulcer with a black eschar. [1] [8] Early lesions may progress to necrotic ulcers in as little as 12 hours. [8] The\u00a0lesions can\u00a0be localized\u00a0and solitary, or widespread. [1]"}
{"id": "article-20877_9", "title": "Ecthyma Gangrenosum -- History and Physical", "content": "EG can appear anywhere in the body but most commonly affects the anogenital and axillary areas. The gluteal/perineal area is most common (57%), followed by the extremities (30%), the trunk (6%), and the face (6%). [8] Rare cases of periorbital involvement have also been reported. [8] The entire body should be examined for lesions, and any fluctuance or large areas of necrosis should be noted.", "contents": "Ecthyma Gangrenosum -- History and Physical. EG can appear anywhere in the body but most commonly affects the anogenital and axillary areas. The gluteal/perineal area is most common (57%), followed by the extremities (30%), the trunk (6%), and the face (6%). [8] Rare cases of periorbital involvement have also been reported. [8] The entire body should be examined for lesions, and any fluctuance or large areas of necrosis should be noted."}
{"id": "article-20877_10", "title": "Ecthyma Gangrenosum -- Evaluation", "content": "Initial evaluation includes blood cultures, wound cultures, urinalysis, chest radiograph, complete blood count, comprehensive metabolic panel, C-reactive protein, and HIV testing. Procalcitonin and lactate levels are important in those with\u00a0EG in the setting of sepsis. Evaluation of the lesions with a Wood's lamp may expedite the diagnosis, as P. aeruginosa will appear with green fluorescence. [8] [16] Excisional\u00a0or\u00a0punch biopsy can\u00a0be performed in equivocal cases.", "contents": "Ecthyma Gangrenosum -- Evaluation. Initial evaluation includes blood cultures, wound cultures, urinalysis, chest radiograph, complete blood count, comprehensive metabolic panel, C-reactive protein, and HIV testing. Procalcitonin and lactate levels are important in those with\u00a0EG in the setting of sepsis. Evaluation of the lesions with a Wood's lamp may expedite the diagnosis, as P. aeruginosa will appear with green fluorescence. [8] [16] Excisional\u00a0or\u00a0punch biopsy can\u00a0be performed in equivocal cases."}
{"id": "article-20877_11", "title": "Ecthyma Gangrenosum -- Treatment / Management", "content": "In individuals with suspected ecthyma gangrenosum,\u00a0prompt treatment\u00a0with broad-spectrum antibiotics should\u00a0be\u00a0initiated after obtaining blood and wound cultures.", "contents": "Ecthyma Gangrenosum -- Treatment / Management. In individuals with suspected ecthyma gangrenosum,\u00a0prompt treatment\u00a0with broad-spectrum antibiotics should\u00a0be\u00a0initiated after obtaining blood and wound cultures."}
{"id": "article-20877_12", "title": "Ecthyma Gangrenosum -- Treatment / Management", "content": "Initial empiric therapy includes antipseudomonal\u00a0beta-lactams (piperacillin/tazobactam), cephalosporins (cefepime), fluoroquinolones (levofloxacin), and\u00a0carbapenems (imipenem). Combination therapy\u00a0is recommended\u00a0in high-risk individuals, such as those with neutropenia and septic shock. [12] Once the\u00a0causative organism and antimicrobial susceptibilities\u00a0are identified, antimicrobial coverage should be narrowed. [2] In rare cases\u00a0with a fungal or viral\u00a0etiology,\u00a0anti-fungal and anti-viral agents should be started.", "contents": "Ecthyma Gangrenosum -- Treatment / Management. Initial empiric therapy includes antipseudomonal\u00a0beta-lactams (piperacillin/tazobactam), cephalosporins (cefepime), fluoroquinolones (levofloxacin), and\u00a0carbapenems (imipenem). Combination therapy\u00a0is recommended\u00a0in high-risk individuals, such as those with neutropenia and septic shock. [12] Once the\u00a0causative organism and antimicrobial susceptibilities\u00a0are identified, antimicrobial coverage should be narrowed. [2] In rare cases\u00a0with a fungal or viral\u00a0etiology,\u00a0anti-fungal and anti-viral agents should be started."}
{"id": "article-20877_13", "title": "Ecthyma Gangrenosum -- Treatment / Management", "content": "Surgical excision of necrotic lesions or abscesses is often necessary. Incision and drainage of abscesses are important for source control of the infection. For necrotic skin lesions, aggressive debridement and grafting may be necessary for lesions larger than 10 cm. [8]", "contents": "Ecthyma Gangrenosum -- Treatment / Management. Surgical excision of necrotic lesions or abscesses is often necessary. Incision and drainage of abscesses are important for source control of the infection. For necrotic skin lesions, aggressive debridement and grafting may be necessary for lesions larger than 10 cm. [8]"}
{"id": "article-20877_14", "title": "Ecthyma Gangrenosum -- Treatment / Management", "content": "Treatment in the hospital intensive care setting is appropriate for\u00a0patients with sepsis or neutropenia due to the high case fatality rate. For those with non-bacteremic EG, treatment in the outpatient setting may be appropriate. In this setting, oral antipseudomonal agents, such as ciprofloxacin, can be considered.", "contents": "Ecthyma Gangrenosum -- Treatment / Management. Treatment in the hospital intensive care setting is appropriate for\u00a0patients with sepsis or neutropenia due to the high case fatality rate. For those with non-bacteremic EG, treatment in the outpatient setting may be appropriate. In this setting, oral antipseudomonal agents, such as ciprofloxacin, can be considered."}
{"id": "article-20877_15", "title": "Ecthyma Gangrenosum -- Differential Diagnosis", "content": "A thorough history, physical, and basic laboratory studies help differentiate between EG and other causes of skin necrosis. Neutropenia and malignancy in a patient with typical skin lesions should raise suspicion for EG.\u00a0Other conditions with similar macroscopic features include autoimmune vasculitides, vasopressor-induced necrosis, calciphylaxis, warfarin-induced necrosis, and disseminated intravascular coagulation (DIC), pyoderma gangrenosum,\u00a0necrolytic migratory erythema, and\u00a0livedoid vasculopathy. [1] [17] [18]", "contents": "Ecthyma Gangrenosum -- Differential Diagnosis. A thorough history, physical, and basic laboratory studies help differentiate between EG and other causes of skin necrosis. Neutropenia and malignancy in a patient with typical skin lesions should raise suspicion for EG.\u00a0Other conditions with similar macroscopic features include autoimmune vasculitides, vasopressor-induced necrosis, calciphylaxis, warfarin-induced necrosis, and disseminated intravascular coagulation (DIC), pyoderma gangrenosum,\u00a0necrolytic migratory erythema, and\u00a0livedoid vasculopathy. [1] [17] [18]"}
{"id": "article-20877_16", "title": "Ecthyma Gangrenosum -- Differential Diagnosis", "content": "In individuals with underlying malignancy and pancytopenia,\u00a0fibrinogen levels and fibrin split products (d-dimer) can help differentiate DIC from EG. In individuals in the intensive care unit on vasopressors, the distribution of lesions can help differentiate between vasopressor-induced necrosis and EG.\u00a0Vasopressor-induced necrosis affects the distal extremities, while EG affects the anogenital and axillary areas. [19] Tissue samples\u00a0are critical when the diagnosis is not clear based on less invasive methods. [20]", "contents": "Ecthyma Gangrenosum -- Differential Diagnosis. In individuals with underlying malignancy and pancytopenia,\u00a0fibrinogen levels and fibrin split products (d-dimer) can help differentiate DIC from EG. In individuals in the intensive care unit on vasopressors, the distribution of lesions can help differentiate between vasopressor-induced necrosis and EG.\u00a0Vasopressor-induced necrosis affects the distal extremities, while EG affects the anogenital and axillary areas. [19] Tissue samples\u00a0are critical when the diagnosis is not clear based on less invasive methods. [20]"}
{"id": "article-20877_17", "title": "Ecthyma Gangrenosum -- Prognosis", "content": "The development of\u00a0EG\u00a0lesions in individuals with sepsis\u00a0is associated with a poor prognosis and is fatal in 20% to 77% of patients. [15] [21] In individuals with non-bacteremic EG, the mortality rate is significantly lower at 8%. [15] The underlying\u00a0immunosuppressive state (e.g., malignancy, renal failure, or other) is often the main determinant of clinical outcome. [22] The presence of neutropenia at the time of diagnosis is the most important prognostic factor of mortality. [21]", "contents": "Ecthyma Gangrenosum -- Prognosis. The development of\u00a0EG\u00a0lesions in individuals with sepsis\u00a0is associated with a poor prognosis and is fatal in 20% to 77% of patients. [15] [21] In individuals with non-bacteremic EG, the mortality rate is significantly lower at 8%. [15] The underlying\u00a0immunosuppressive state (e.g., malignancy, renal failure, or other) is often the main determinant of clinical outcome. [22] The presence of neutropenia at the time of diagnosis is the most important prognostic factor of mortality. [21]"}
{"id": "article-20877_18", "title": "Ecthyma Gangrenosum -- Complications", "content": "EG\u00a0is a life-threatening infection often\u00a0complicated by septic shock. Prompt clinician recognition and appropriate antimicrobial therapy\u00a0are necessary to achieve optimal outcomes.", "contents": "Ecthyma Gangrenosum -- Complications. EG\u00a0is a life-threatening infection often\u00a0complicated by septic shock. Prompt clinician recognition and appropriate antimicrobial therapy\u00a0are necessary to achieve optimal outcomes."}
{"id": "article-20877_19", "title": "Ecthyma Gangrenosum -- Deterrence and Patient Education", "content": "Patients need to understand that if they are immunocompromised, that underlying condition requires optimal management. These patients are typically managed in the hospital setting.", "contents": "Ecthyma Gangrenosum -- Deterrence and Patient Education. Patients need to understand that if they are immunocompromised, that underlying condition requires optimal management. These patients are typically managed in the hospital setting."}
{"id": "article-20877_20", "title": "Ecthyma Gangrenosum -- Pearls and Other Issues", "content": "P. aeruginosa is the most common causative organism of ecthyma gangrenosum. Lesions appear as gangrenous ulcers with erythematous borders located predominantly in the axillary and anogenital areas. Nearly all individuals with typical skin lesions are immunocompromised, with malignancy being the most common underlying disease state. Neutropenia at the time of diagnosis is the most important prognostic factor. Prompt treatment with intravenous\u00a0antipseudomonal agents\u00a0is indicated. Incision and drainage may be performed for abscesses.", "contents": "Ecthyma Gangrenosum -- Pearls and Other Issues. P. aeruginosa is the most common causative organism of ecthyma gangrenosum. Lesions appear as gangrenous ulcers with erythematous borders located predominantly in the axillary and anogenital areas. Nearly all individuals with typical skin lesions are immunocompromised, with malignancy being the most common underlying disease state. Neutropenia at the time of diagnosis is the most important prognostic factor. Prompt treatment with intravenous\u00a0antipseudomonal agents\u00a0is indicated. Incision and drainage may be performed for abscesses."}
{"id": "article-20877_21", "title": "Ecthyma Gangrenosum -- Enhancing Healthcare Team Outcomes", "content": "Management of ecthyma gangrenosum requires an interprofessional team approach, including providers from infectious disease, surgery, dermatology, hematology, and critical care.\u00a0The providers involved in treatment\u00a0depend on the overall clinical picture and whether they are being treated in the intensive care unit.", "contents": "Ecthyma Gangrenosum -- Enhancing Healthcare Team Outcomes. Management of ecthyma gangrenosum requires an interprofessional team approach, including providers from infectious disease, surgery, dermatology, hematology, and critical care.\u00a0The providers involved in treatment\u00a0depend on the overall clinical picture and whether they are being treated in the intensive care unit."}
{"id": "article-20877_22", "title": "Ecthyma Gangrenosum -- Enhancing Healthcare Team Outcomes", "content": "A dermatologist can help in the initial diagnostic workup to determine the cause (Wood's lamp evaluation, punch biopsy) and extent of the lesions.\u00a0Infectious\u00a0disease specialists\u00a0are helpful to determine the selection and\u00a0length of antibiotic therapy.\u00a0Surgeons\u00a0may be needed\u00a0for incision and drainage of multiple abscesses, surgical debridement of necrotic lesions, or grafting of large-area defects.\u00a0In patients with neutropenia,\u00a0granulocyte colony-stimulating factor (G-CSF) may be given\u00a0at the discretion of a hematologist.", "contents": "Ecthyma Gangrenosum -- Enhancing Healthcare Team Outcomes. A dermatologist can help in the initial diagnostic workup to determine the cause (Wood's lamp evaluation, punch biopsy) and extent of the lesions.\u00a0Infectious\u00a0disease specialists\u00a0are helpful to determine the selection and\u00a0length of antibiotic therapy.\u00a0Surgeons\u00a0may be needed\u00a0for incision and drainage of multiple abscesses, surgical debridement of necrotic lesions, or grafting of large-area defects.\u00a0In patients with neutropenia,\u00a0granulocyte colony-stimulating factor (G-CSF) may be given\u00a0at the discretion of a hematologist."}
{"id": "article-20877_23", "title": "Ecthyma Gangrenosum -- Enhancing Healthcare Team Outcomes", "content": "For individuals with fulminant sepsis, management in the critical care setting by an intensivist\u00a0is\u00a0appropriate\u00a0due to the high fatality rate of bacteremic\u00a0EG.\u00a0Individuals with sepsis are extremely\u00a0tenuous, and careful monitoring from the nursing staff with frequent vital sign measurements is critical and reporting to the team untoward changes. Prompt administration of effective antimicrobial therapy\u00a0is\u00a0known\u00a0to improve survival in sepsis. [23] [Level\u00a01] Ideally, an infectious disease specialist pharmacist should assist with antibiotic selection and assist the team with dose management. In addition to helping to target the causative organism. Early\u00a0goal-directed therapy focusing on blood pressure and oxygen saturation\u00a0has also\u00a0been shown to improve outcomes and reduce mortality in sepsis. [24] [Level 1]", "contents": "Ecthyma Gangrenosum -- Enhancing Healthcare Team Outcomes. For individuals with fulminant sepsis, management in the critical care setting by an intensivist\u00a0is\u00a0appropriate\u00a0due to the high fatality rate of bacteremic\u00a0EG.\u00a0Individuals with sepsis are extremely\u00a0tenuous, and careful monitoring from the nursing staff with frequent vital sign measurements is critical and reporting to the team untoward changes. Prompt administration of effective antimicrobial therapy\u00a0is\u00a0known\u00a0to improve survival in sepsis. [23] [Level\u00a01] Ideally, an infectious disease specialist pharmacist should assist with antibiotic selection and assist the team with dose management. In addition to helping to target the causative organism. Early\u00a0goal-directed therapy focusing on blood pressure and oxygen saturation\u00a0has also\u00a0been shown to improve outcomes and reduce mortality in sepsis. [24] [Level 1]"}
{"id": "article-20877_24", "title": "Ecthyma Gangrenosum -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Ecthyma Gangrenosum -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}